Histidine-rich protein (hrp) 2-based RDT false-negatives and Plasmodium falciparum hrp 2 and 3 gene deletions in low, seasonal and intense perennial transmission zones in Cameroon: a cross - sectional study

• Published in: BMC infectious diseases Vol. 24; no. 1; pp. 1080 - 14
• Main Authors: Apinjoh, Tobias Obejum, Tangi, Livinus Ngu, Oriero, Eniyou Cheryll, Drammeh, Sainabou, Ntui-Njock, Vincent Ntui, Etoketim, Blessed, Chi, Hanesh Fru, Kwi, Pilate Nkineh, Njie, Bekai, Oboh, Mary Aigbiremo, Achidi, Eric Akum, Amambua-Ngwa, Alfred
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 30.09.2024; BioMed Central; BMC
• Subjects: Adolescent; Adult; Aged; Antigens; Antigens, Protozoan - genetics; Blood; Blood parasites; Cameroon - epidemiology; Care and treatment; Child; Child, Preschool; Community; Cross-Sectional Studies; Diagnosis; Diagnostic tests; Diagnostic Tests, Routine; Disease transmission; Displaced persons; Ethylenediaminetetraacetic acid; False Negative Reactions; Female; Gene Deletion; Genes; Genetic aspects; Genetic research; Genotypes; Health care facilities; Health facilities; Histidine; Histidine-rich protein; Hospital facilities; Humans; Infant; Malaria; Malaria diagnosis; Malaria, Falciparum - epidemiology; Malaria, Falciparum - parasitology; Malaria, Falciparum - transmission; Male; Medical tests; Methods; Microscopy; Middle Aged; Parasites; Peripheral blood; Physiological aspects; Plasmodium; Plasmodium falciparum; Plasmodium falciparum - genetics; Polymerase chain reaction; Population; Prevalence; Proteins; Protozoan Proteins - genetics; Public health; Real time; Rural areas; Seasons; Vector-borne diseases; Young Adult; Cameroon; Nigeria; Africa; Plasmodium falciparum; Malaria diagnosis; Gene deletion; Histidine-rich protein
• ISSN: 1471-2334; 1471-2334
• DOI: 10.1186/s12879-024-09935-4

False negative rapid diagnostic tests (RDTs) accruing to the non-detection of Plasmodium falciparum histidine-rich protein 2/3 (Pfhrp2/3) is threatening the diagnosis and management of malaria. Although regular monitoring is necessary to gauge the level of efficacy of the tool, studies in Cameroon remain limited. This study assessed Plasmodium spp. prevalence and Pfhrp2/3 gene deletions across ecological and transmission zones in Cameroon. This is a cross-sectional, multi-site, community- and hospital- based study, in 21 health facilities and 14 communities covering all five ecological settings in low seasonal (LS) and intense perennial (IPT) malaria transmission zones between 2019 and 2021. Participants were screened for malaria parasite using Pfhrp2 RDT and light microscopic examination of thick peripheral blood smears. DNA was extracted from dried blood spot using chelex -100 and P. falciparum confirmed using varATS real-time quantitative Polymerase Chain Reaction (qPCR), P. malariae and P. ovale by real-time qPCR of Plasmepsin gene, and P. vivax using a commercial kit. Isolates with amplified Pfcsp and Pfama-1 genes were assayed for Pfhrp 2/3 gene deletions by conventional PCR. A total of 3,373 participants enrolled, 1,786 Plasmodium spp. infected, with 77.4% P. falciparum. Discordant RDT and qPCR results (False negatives) were reported in 191 (15.7%) P. falciparum mono-infected samples from LS (29%, 42) and IPT (13.9%, 149). The Pfhrp2+/Pfhrp3 + genotype was most frequent, similar between LS (5.5%, 8/145) and IPT (6.0%, 65/1,076). Single Pfhrp2 and Pfhrp3 gene deletions occurred in LS (0.7%, 1/145 each) and IPT (3.6%, 39/1,076 vs. 2.9%, 31/1,076), respectively. Whilst a single sample harboured Pfhrp2-/Pfhrp3- genotype in LS, 2.4% (26/1,076) were double deleted at IPT. Pfhrp2+/Pfhrp3- (0.3%, 3/1,076) and Pfhrp2-/Pfhrp3+ (1.2%, 13/1,076) genotypes were only observed in IPT. Pfhrp2, Pfhrp3 deletions and Pfhrp2-/Pfhrp3- genotype accounted for 78.8% (26), 69.7% (23) and 63.6% (21) RDT false negatives, respectively. Plasmodium falciparum remains the most dominant and widely distributed Plasmodium species across transmission and ecological zones in Cameroon. Although the low prevalence of Pfhrp2/3 gene deletions supports the continued use of HRP2-based RDTs for routine malaria diagnosis, the high proportion of false-negatives due to gene deleted parasites necessitates continued surveillance to inform control and elimination efforts.